Christina Cameron

Investor Relations Contact at ANTIBE THERAPEUTICS INC.

Health Technology

Consumer Services

Profile

Christina Cameron is currently working as the Director-Investor Relations at Medicago, Inc. and as the Vice President-Investor Relations at Antibe Therapeutics, Inc. She completed her undergraduate degree from Wilfrid Laurier University.

Christina Cameron active positions

Companies	Position	Start
ANTIBE THERAPEUTICS INC.	Investor Relations Contact	-
Medicago, Inc. Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.	Investor Relations Contact	-

All active positions of Christina Cameron

Training of Christina Cameron

Wilfrid Laurier University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christina Cameron's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ANTIBE THERAPEUTICS INC.	Health Technology

Private companies	1
Medicago, Inc. Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.	Health Technology